TipRanks
Go Ultimate55% OFF

ME Therapeutics Holdings, Inc. (METX) Ratios

ME Therapeutics Holdings, Inc. Ratios

TSE:METX's free cash flow for Q4 2024 was $-150.26K. For the 2024 fiscal year, TSE:METX's free cash flow was increased by ― and operating cash flow was ―. See a summary of the company’s cash flow.

Financial ratios
RatiosAug 24Aug 23Sep 22
Liquidity Ratios
Leverage Ratios
Profitability Margins
Efficiency Ratios
Cash Flow Ratios
Valuation Ratios
Tax and Other Ratios

Currency in USD